Does TRT really cause hair loss? We fact-checked

What does this video actually claim?

@coachdarianbates tackles a common TRT concern: whether testosterone replacement therapy causes male pattern baldness. He explains that TRT can accelerate hair loss in men who are genetically predisposed to it, but won't cause baldness in men without that genetic vulnerability.

The creator correctly identifies DHT (dihydrotestosterone) as the culprit behind androgenic alopecia. He explains that testosterone converts to DHT via the 5-alpha-reductase enzyme, and DHT binds to hair follicle receptors in genetically susceptible men.

Bates also mentions that some TRT patients use finasteride to block DHT production and potentially prevent hair loss while on testosterone therapy.

Does the science back this up?

The basic science here is solid. Multiple studies confirm that androgenic alopecia requires both genetic predisposition and sufficient androgen levels. A 2016 review by Lolli et al. in Drug Design Reviews found that men with androgenic alopecia have increased 5-alpha-reductase activity and DHT sensitivity in scalp hair follicles.

Research shows testosterone levels don't directly correlate with hair loss severity. The Framingham Heart Study (Lolli et al., 2017) found no association between serum testosterone and male pattern baldness progression in 1,216 men.

However, exogenous testosterone can accelerate existing hair loss patterns. A 2014 study by Irwig in the Journal of Clinical Medicine found that 37% of men starting TRT experienced some degree of hair loss acceleration within the first year.

What about the finasteride solution?

Bates correctly identifies finasteride as a potential solution, but he undersells the complexity. Finasteride blocks type II 5-alpha-reductase, reducing DHT by approximately 70% according to the original Merck trials (Kaufman et al., JAAD, 1998).

The drug works for hair preservation in about 83% of men over two years. But combining finasteride with TRT creates competing forces: you're adding testosterone while blocking its conversion to DHT.

Some men on this combination still experience hair loss because finasteride doesn't eliminate DHT entirely. Plus, the drug carries its own risks including potential sexual side effects that persist in roughly 1.4% of users (Irwig, Journal of Sexual Medicine, 2012).

What's missing from this advice?

The video oversimplifies the genetic component. Hair loss susceptibility isn't binary. You don't either have "the gene" or you don't.

Androgenic alopecia involves multiple genetic variants. Research by Heilmann-Heimbach et al. (Nature Communications, 2017) identified 63 genetic loci associated with male pattern baldness. This means hair loss risk exists on a spectrum.

Bates also doesn't mention that TRT dosing matters. Higher testosterone doses create more substrate for DHT conversion. Men on 200mg weekly protocols face different hair loss risks than those on 100mg weekly, though specific dose-response studies for TRT and hair loss are limited.

What should you actually know?

TRT will likely accelerate hair loss if you're already losing hair or have strong family history of baldness. If you've maintained a full hairline into your 40s with no family history, TRT probably won't trigger sudden baldness.

The finasteride option isn't risk-free. Sexual side effects occur in roughly 15% of users during treatment, with persistent effects in a small subset. Some men find this trade-off unacceptable.

Consider starting TRT at lower doses if hair preservation is a priority. You can always increase later, but you can't undo accelerated hair loss. Topical treatments like minoxidil can also help maintain hair density during TRT.